Mechanisms of CHD5 Inactivation in Neuroblastomas

PURPOSE: Neuroblastomas (NBs) have genomic, biological and clinical heterogeneity. High-risk NBs are characterized by several genomic changes, including MYCN amplification and 1p36 deletion. We identified the chromatin-remodeling gene CHD5 as a tumor suppressor gene that maps to 1p36.31. Low or abse...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Koyama, Hiroshi, Zhuang, Tiangang, Light, Jennifer E., Kolla, Venkatadri, Higashi, Mayumi, McGrady, Patrick W., London, Wendy B., Brodeur, Garrett M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306487/
https://ncbi.nlm.nih.gov/pubmed/22294723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2644
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items